Mapatumumab: Interim Phase Ib data

Interim data from an open-label, dose-escalation, Dutch Phase Ib trial in 16 evaluable patients showed that HGS-ETR1 in combination with gemcitabine and cisplatin was safe and well tolerated. The comb...